Non-ABO red cell antibodies and risk of COVID-19

It is not known whether non-ABO antibodies confer any protective effect against SARS-CoV-2 infection or COVID-19 severe illness alone or in conjunction with O blood group. This cohort study included 413 576 persons in Ontario, Canada with known ABO blood group and non-ABO antibody screen status, who...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Joel G., Colacci, Michael, Schull, Michael J., Vermeulen, Marian J., Park, Alison L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132504/
https://www.ncbi.nlm.nih.gov/pubmed/34022334
http://dx.doi.org/10.1016/j.ijid.2021.05.038
_version_ 1783694925311770624
author Ray, Joel G.
Colacci, Michael
Schull, Michael J.
Vermeulen, Marian J.
Park, Alison L.
author_facet Ray, Joel G.
Colacci, Michael
Schull, Michael J.
Vermeulen, Marian J.
Park, Alison L.
author_sort Ray, Joel G.
collection PubMed
description It is not known whether non-ABO antibodies confer any protective effect against SARS-CoV-2 infection or COVID-19 severe illness alone or in conjunction with O blood group. This cohort study included 413 576 persons in Ontario, Canada with known ABO blood group and non-ABO antibody screen status, who subsequently underwent SARS-CoV-2 viral RNA polymerase chain reaction testing between January and November 2020. The risk of SARS-CoV-2 infection or COVID-19 severe illness was not associated with the presence of non-ABO antibodies, even among persons with O blood group.
format Online
Article
Text
id pubmed-8132504
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-81325042021-05-19 Non-ABO red cell antibodies and risk of COVID-19 Ray, Joel G. Colacci, Michael Schull, Michael J. Vermeulen, Marian J. Park, Alison L. Int J Infect Dis Short Communication It is not known whether non-ABO antibodies confer any protective effect against SARS-CoV-2 infection or COVID-19 severe illness alone or in conjunction with O blood group. This cohort study included 413 576 persons in Ontario, Canada with known ABO blood group and non-ABO antibody screen status, who subsequently underwent SARS-CoV-2 viral RNA polymerase chain reaction testing between January and November 2020. The risk of SARS-CoV-2 infection or COVID-19 severe illness was not associated with the presence of non-ABO antibodies, even among persons with O blood group. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-07 2021-05-19 /pmc/articles/PMC8132504/ /pubmed/34022334 http://dx.doi.org/10.1016/j.ijid.2021.05.038 Text en © 2021 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Ray, Joel G.
Colacci, Michael
Schull, Michael J.
Vermeulen, Marian J.
Park, Alison L.
Non-ABO red cell antibodies and risk of COVID-19
title Non-ABO red cell antibodies and risk of COVID-19
title_full Non-ABO red cell antibodies and risk of COVID-19
title_fullStr Non-ABO red cell antibodies and risk of COVID-19
title_full_unstemmed Non-ABO red cell antibodies and risk of COVID-19
title_short Non-ABO red cell antibodies and risk of COVID-19
title_sort non-abo red cell antibodies and risk of covid-19
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132504/
https://www.ncbi.nlm.nih.gov/pubmed/34022334
http://dx.doi.org/10.1016/j.ijid.2021.05.038
work_keys_str_mv AT rayjoelg nonaboredcellantibodiesandriskofcovid19
AT colaccimichael nonaboredcellantibodiesandriskofcovid19
AT schullmichaelj nonaboredcellantibodiesandriskofcovid19
AT vermeulenmarianj nonaboredcellantibodiesandriskofcovid19
AT parkalisonl nonaboredcellantibodiesandriskofcovid19

Ejemplares similares